Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 9, Pages 1390
Publisher
MDPI AG
Online
2019-09-18
DOI
10.3390/cancers11091390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase
- (2019) Belén G. Sánchez et al. Cancer Cell International
- Hypoxia-inducible factor-1α induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells
- (2019) Santosh Kumar Singh et al. Journal of Ovarian Research
- Thymoquinone: A novel strategy to combat cancer: A review
- (2018) Muhammad Imran et al. BIOMEDICINE & PHARMACOTHERAPY
- Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
- (2018) Santosh Kumar Singh et al. CANCER LETTERS
- Recent Advances in Prostate Cancer Treatment and Drug Discovery
- (2018) Ekaterina Nevedomskaya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
- (2018) Emelie Berglund et al. Nature Communications
- Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer
- (2017) Sang Eun Park et al. INVESTIGATIONAL NEW DRUGS
- Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway
- (2017) Li-Min Feng et al. JOURNAL OF BIOSCIENCES
- Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
- (2017) Verónica Cánovas et al. Oncotarget
- Thymoquinone, as an anticancer molecule: from basic research to clinical investigation
- (2017) Md. Asaduzzaman Khan et al. Oncotarget
- Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway
- (2017) Santosh Kumar Singh et al. Oncotarget
- Treatment of Advanced Prostate Cancer—A Review of Current Therapies and Future Promise
- (2017) Semini Sumanasuriya et al. Cold Spring Harbor Perspectives in Medicine
- Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
- (2016) Gwenaelle Gravis et al. EUROPEAN UROLOGY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer
- (2016) Marco A. De Velasco et al. Oncotarget
- Signal Transduction in Cancer
- (2015) R. Sever et al. Cold Spring Harbor Perspectives in Medicine
- Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
- (2014) PAUL TOREN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Presentation and management of docetaxel-related adverse effects in patients with breast cancer
- (2014) Maria Ho et al. Cancer Management and Research
- Thymoquinone Induces Mitochondria-Mediated Apoptosis in Acute Lymphoblastic Leukaemia in Vitro
- (2013) Landa Salim et al. MOLECULES
- Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
- (2012) N. Floc'h et al. CANCER RESEARCH
- Anticancer Activities of Nigella sativa (Black Cumin)
- (2011) A Khan et al. African Journal of Traditional Complementary and Alternative Medicines
- Anticancer Activity of Nigella sativa (Black Seed) — A Review
- (2011) Mohammad Akram Randhawa et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway
- (2011) J. J. Wallin et al. MOLECULAR CANCER THERAPEUTICS
- Docetaxel-based combination therapy for castration-resistant prostate cancer
- (2010) M. D. Galsky et al. ANNALS OF ONCOLOGY
- Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
- (2009) D. Sarker et al. CLINICAL CANCER RESEARCH
- REMOVED: Docetaxel-related side effects and their management
- (2008) Jackie Baker et al. European Journal of Oncology Nursing
- Preclinicalversusclinical drug combination studies
- (2008) Ting-Chao Chou LEUKEMIA & LYMPHOMA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now